1. Home
  2. TOUR vs SCLX Comparison

TOUR vs SCLX Comparison

Compare TOUR & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuniu Corporation

TOUR

Tuniu Corporation

HOLD

Current Price

$5.10

Market Cap

57.6M

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.85

Market Cap

55.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOUR
SCLX
Founded
2006
2011
Country
China
United States
Employees
N/A
34
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.6M
55.1M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
TOUR
SCLX
Price
$5.10
$6.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.4K
106.3K
Earning Date
06-11-2026
04-10-2026
Dividend Yield
17.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.30
$122.52
Revenue Next Year
$14.00
$186.30
P/E Ratio
$87.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$4.20
52 Week High
$7.79
$34.27

Technical Indicators

Market Signals
Indicator
TOUR
SCLX
Relative Strength Index (RSI) 54.72 41.02
Support Level $0.66 $5.72
Resistance Level $5.28 $7.77
Average True Range (ATR) 0.13 1.02
MACD 0.05 -0.26
Stochastic Oscillator 57.14 4.02

Price Performance

Historical Comparison
TOUR
SCLX

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. The company offers a large selection of packaged tours, including organized tours and self-guided tours, and travel-related services for leisure travellers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: